TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Teligent Inc (NASDAQ:TLGT) Investor Investigation Announced

  • If you purchased shares of Teligent Inc (NASDAQ:TLGT), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Teligent Inc
Security
NASDAQ: TLGT

Summary

January 18, 2017 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Teligent Inc (NASDAQ:TLGT) was announced over potential breaches of fiduciary duties by certain officers and directors at Teligent Inc.

The investigation by a law firm concerns whether certain Teligent Inc officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Buena, Nj based Teligent, Inc., formerly IGI Laboratories, Inc., is a specialty generic pharmaceutical company. Teligent Inc reported that its annual Total Revenue rose from $33.74 million in 2014 to $44.25 million in 2015 and that its Net Income increased from $5.25 million in 2014 to $6.67 million in 2015. Shares of Teligent Inc (NASDAQ:TLGT) reached in 2015 as high as $11.52 per share.

On January 18, 2017, NASDAQ:TLGT shares closed at $6.78 per share.

Start Monitoring Your Investments